Cargando…

A Survey of Cannabis Use among Patients with Inflammatory Bowel Disease (IBD)

Inflammatory bowel diseases (IBDs) are chronic conditions of unknown cause or cure. Treatment seeks to reduce symptoms and induce and maintain remission. Many patients have turned to alternatives, such as cannabis, to alleviate living with IBD. This study reports the demographics, prevalence, and pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Velez-Santiago, Alondra, Alvarez-Torres, Edwin, Martinez-Rodriguez, Ricardo, Candal-Rivera, Emmanuel, Muniz-Camacho, Luis, Ramos-Burgos, Luis, Torres, Esther A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10049263/
https://www.ncbi.nlm.nih.gov/pubmed/36982049
http://dx.doi.org/10.3390/ijerph20065129
_version_ 1785014414684979200
author Velez-Santiago, Alondra
Alvarez-Torres, Edwin
Martinez-Rodriguez, Ricardo
Candal-Rivera, Emmanuel
Muniz-Camacho, Luis
Ramos-Burgos, Luis
Torres, Esther A.
author_facet Velez-Santiago, Alondra
Alvarez-Torres, Edwin
Martinez-Rodriguez, Ricardo
Candal-Rivera, Emmanuel
Muniz-Camacho, Luis
Ramos-Burgos, Luis
Torres, Esther A.
author_sort Velez-Santiago, Alondra
collection PubMed
description Inflammatory bowel diseases (IBDs) are chronic conditions of unknown cause or cure. Treatment seeks to reduce symptoms and induce and maintain remission. Many patients have turned to alternatives, such as cannabis, to alleviate living with IBD. This study reports the demographics, prevalence, and perception on cannabis use of patients attending an IBD clinic. Patients agreed to participate and completed an anonymous survey during their visit or online. Descriptive analysis, Fisher’s exact test, and Wilcoxon-Mann-Whitney rank-sum test were used. One hundred and sixty-two adults (85 males, 77 with CD) completed the survey. Sixty (37%) reported use of cannabis, of which 38 (63%) used it to relieve their IBD. A value of 77% reported low to moderate knowledge about cannabis, and 15% reported little to no knowledge. Among cannabis users, 48% had discussed use with their physician, but 88% said they would feel comfortable discussing medical cannabis for IBD. Most saw improvement of their symptoms (85.7%). A considerable number of patients with IBD use medical cannabis for their disease, unknown to their physician. The study reinforces the importance that physicians understand the role of cannabis in the treatment of IBD in order to appropriately counsel patients.
format Online
Article
Text
id pubmed-10049263
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100492632023-03-29 A Survey of Cannabis Use among Patients with Inflammatory Bowel Disease (IBD) Velez-Santiago, Alondra Alvarez-Torres, Edwin Martinez-Rodriguez, Ricardo Candal-Rivera, Emmanuel Muniz-Camacho, Luis Ramos-Burgos, Luis Torres, Esther A. Int J Environ Res Public Health Article Inflammatory bowel diseases (IBDs) are chronic conditions of unknown cause or cure. Treatment seeks to reduce symptoms and induce and maintain remission. Many patients have turned to alternatives, such as cannabis, to alleviate living with IBD. This study reports the demographics, prevalence, and perception on cannabis use of patients attending an IBD clinic. Patients agreed to participate and completed an anonymous survey during their visit or online. Descriptive analysis, Fisher’s exact test, and Wilcoxon-Mann-Whitney rank-sum test were used. One hundred and sixty-two adults (85 males, 77 with CD) completed the survey. Sixty (37%) reported use of cannabis, of which 38 (63%) used it to relieve their IBD. A value of 77% reported low to moderate knowledge about cannabis, and 15% reported little to no knowledge. Among cannabis users, 48% had discussed use with their physician, but 88% said they would feel comfortable discussing medical cannabis for IBD. Most saw improvement of their symptoms (85.7%). A considerable number of patients with IBD use medical cannabis for their disease, unknown to their physician. The study reinforces the importance that physicians understand the role of cannabis in the treatment of IBD in order to appropriately counsel patients. MDPI 2023-03-15 /pmc/articles/PMC10049263/ /pubmed/36982049 http://dx.doi.org/10.3390/ijerph20065129 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Velez-Santiago, Alondra
Alvarez-Torres, Edwin
Martinez-Rodriguez, Ricardo
Candal-Rivera, Emmanuel
Muniz-Camacho, Luis
Ramos-Burgos, Luis
Torres, Esther A.
A Survey of Cannabis Use among Patients with Inflammatory Bowel Disease (IBD)
title A Survey of Cannabis Use among Patients with Inflammatory Bowel Disease (IBD)
title_full A Survey of Cannabis Use among Patients with Inflammatory Bowel Disease (IBD)
title_fullStr A Survey of Cannabis Use among Patients with Inflammatory Bowel Disease (IBD)
title_full_unstemmed A Survey of Cannabis Use among Patients with Inflammatory Bowel Disease (IBD)
title_short A Survey of Cannabis Use among Patients with Inflammatory Bowel Disease (IBD)
title_sort survey of cannabis use among patients with inflammatory bowel disease (ibd)
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10049263/
https://www.ncbi.nlm.nih.gov/pubmed/36982049
http://dx.doi.org/10.3390/ijerph20065129
work_keys_str_mv AT velezsantiagoalondra asurveyofcannabisuseamongpatientswithinflammatoryboweldiseaseibd
AT alvareztorresedwin asurveyofcannabisuseamongpatientswithinflammatoryboweldiseaseibd
AT martinezrodriguezricardo asurveyofcannabisuseamongpatientswithinflammatoryboweldiseaseibd
AT candalriveraemmanuel asurveyofcannabisuseamongpatientswithinflammatoryboweldiseaseibd
AT munizcamacholuis asurveyofcannabisuseamongpatientswithinflammatoryboweldiseaseibd
AT ramosburgosluis asurveyofcannabisuseamongpatientswithinflammatoryboweldiseaseibd
AT torresesthera asurveyofcannabisuseamongpatientswithinflammatoryboweldiseaseibd
AT velezsantiagoalondra surveyofcannabisuseamongpatientswithinflammatoryboweldiseaseibd
AT alvareztorresedwin surveyofcannabisuseamongpatientswithinflammatoryboweldiseaseibd
AT martinezrodriguezricardo surveyofcannabisuseamongpatientswithinflammatoryboweldiseaseibd
AT candalriveraemmanuel surveyofcannabisuseamongpatientswithinflammatoryboweldiseaseibd
AT munizcamacholuis surveyofcannabisuseamongpatientswithinflammatoryboweldiseaseibd
AT ramosburgosluis surveyofcannabisuseamongpatientswithinflammatoryboweldiseaseibd
AT torresesthera surveyofcannabisuseamongpatientswithinflammatoryboweldiseaseibd